Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?
Amini N, Andreatos N, Margonis GA, Buettner S, Wang J, Galjart B, Wagner D, Sasaki K, Angelou A, Sun J, Kamphues C, Beer A, Morioka D, Løes IM, Antoniou E, Imai K, Pikoulis E, He J, Kaczirek K, Poultsides G, Verhoef C, Lønning PE, Endo I, Baba H, Kornprat P, NAucejo F, Kreis ME, Christopher WL, Weiss MJ, Safar B, Burkhart RA.
Amini N, et al. Among authors: sun j.
J Hepatobiliary Pancreat Sci. 2022 Apr;29(4):417-427. doi: 10.1002/jhbp.1054. Epub 2021 Oct 20.
J Hepatobiliary Pancreat Sci. 2022.
PMID: 34614304